<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6336248\results\search\disease\results.xml">
  <result pre="source are credited.pntd.0006919.pdf Abstract Chikungunya fever (CHIKF) is an emerging" exact="infectious disease" post="caused by an alphavirus transmitted by Aedes spp. mosquitoes."/>
  <result pre="mosquitoes. Infection with CHIKV typically causes a self-limiting febrile illness," exact="chikungunya" post="fever (CHIKF), characterized by chronic, severe joint pain, and"/>
  <result pre="Health Organization (http://www.who.int/emergencies/diseases/chikungunya/en/) and Pan American Health Organization (https://www.paho.org/hq/index.php?option=com_topics&amp;amp;view=article&amp;amp;id=343&amp;amp;Itemid=40931&amp;amp;lang=en). CHIKV," exact="chikungunya" post="virus. Secondly, although the caseâ€&quot;fatality rate of CHIKF is"/>
  <result pre="alphaviruses are not considered neurotropic sensu strictu [18], cases of" exact="meningoencephalitis" post="have been documented, especially during Indian outbreaks [1], and"/>
  <result pre="have been documented, especially during Indian outbreaks [1], and fatal" exact="encephalitis" post="has been reported with CHIKV infection both in Italy"/>
  <result pre="Unlike other mosquito-borne viruses such as dengue, Zika, and even" exact="yellow fever," post="CHIKV typically causes symptomatic infection, and consequently outbreaks are"/>
  <result pre="previously vaccinated with other live-attenuated alphavirus vaccines (i.e., Venezuelan equine" exact="encephalitis" post="virus), suggesting immunological interference [35]. Ultimately, development of this"/>
  <result pre="[49, 50] MV-CHIK Inst. Pasteur, Themis Bioscience Recombinant live- attenuated" exact="measles" post="vaccine expressing CHIKV virus-like particles derived from the structural"/>
  <result pre="preclinical (immunogenicity and efficacy in mice, NHPs) [48] Abbreviations: CHIKF," exact="chikungunya" post="fever; CHIKV, chikungunya virus; EILV, Eilat virus; NHP, nonhuman"/>
  <result pre="efficacy in mice, NHPs) [48] Abbreviations: CHIKF, chikungunya fever; CHIKV," exact="chikungunya" post="virus; EILV, Eilat virus; NHP, nonhuman primate; nsP3, nonstructural"/>
  <result pre="vaccine in advanced stages of clinical development employs an attenuated" exact="measles" post="virus strain as a vector to express the CHIKV"/>
  <result pre="with adequate incidence of CHIKF to demonstrate efficacy. Bottlenecks for" exact="chikungunya" post="vaccine development: Which obstacles should be removed? CHIKF outbreak"/>
  <result pre="long-term protection in endemic locations. Viral-vectored platforms such as vesicular" exact="stomatitis" post="or measles can also be rapidly adapted for new"/>
  <result pre="in endemic locations. Viral-vectored platforms such as vesicular stomatitis or" exact="measles" post="can also be rapidly adapted for new viral targets"/>
  <result pre="endemic for CHIKF, but the typical misdiagnosis of CHIKF as" exact="dengue fever" post="[56] will need to be overcome with improved surveillance"/>
  <result pre="efficacy to human protection. Further work to model arthralgia and" exact="arthritis" post="in NHPs could greatly enhance the value of preclinical"/>
  <result pre="ME, Riccardo F, Severini F, et al. Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017. Euro"/>
  <result pre="et al. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. The"/>
  <result pre="Sitar S, Plummer SH, et al. Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: a phase 1"/>
  <result pre="2014;20(8):1351â€&quot;4. 10.3201/eid2008.13161525061762 7CassadouS, BoucauS, Petit-SinturelM, HucP, Leparc-GoffartI, LedransM. Emergence of" exact="chikungunya" post="fever on the French side of Saint Martin island,"/>
  <result pre=".24721536 8RezzaG, NicolettiL, AngeliniR, RomiR, FinarelliAC, PanningM, et al.Infection with" exact="chikungunya" post="virus in Italy: an outbreak in a temperate region."/>
  <result pre="Di LucaM, FortunaC, RemoliME, RiccardoF, SeveriniF, et al.Detection of a" exact="chikungunya" post="outbreak in Central Italy, August to September 2017. Euro"/>
  <result pre="Vaccine. 2017;35(37):4851â€&quot;8. 10.1016/j.vaccine.2017.07.065 .28760614 14TsetsarkinKA, ChenR, WeaverSC. Interspecies transmission and" exact="chikungunya" post="virus emergence. Curr Opin Virol. 2016;16:143â€&quot;50. 10.1016/j.coviro.2016.02.00726986235 15TsetsarkinKA, ChenR,"/>
  <result pre="ChenR, YunR, RossiSL, PlanteKS, GuerboisM, et al.Multi-peaked adaptive landscape for" exact="chikungunya" post="virus evolution predicts continued fitness optimization in Aedes albopictus"/>
  <result pre="MakhanM, MoheeputK. Excess mortality as an epidemic intelligence tool in" exact="chikungunya" post="mapping. Euro Surveill. 2008;13(7). Epub 2008/05/01. .18445418 18ArpinoC, CuratoloP,"/>
  <result pre=".26690898 21QueyriauxB, SimonF, GrandadamM, MichelR, TolouH, BoutinJP. Clinical burden of" exact="chikungunya" post="virus infection. Lancet Infect Dis. 2008;8(1):2â€&quot;3. 10.1016/S1473-3099(07)70294-3 .18156079 22SissokoD,"/>
  <result pre="and rheumatoid-like polyarthritis more than 2 years after infection with" exact="chikungunya" post="virus. Postgraduate Med J. 2013;89(1054):440â€&quot;7. 10.1136/postgradmedj-2012-131477 .23645664 24MoroML, GrilliE,"/>
  <result pre="10.1136/postgradmedj-2012-131477 .23645664 24MoroML, GrilliE, CorvettaA, SilviG, AngeliniR, MascellaF, et al.Long-term" exact="chikungunya" post="infection clinical manifestations after an outbreak in Italy: a"/>
  <result pre="2011/06/23. 10.1371/journal.pntd.000119721695162 26Shepard DS. Cost and burden of dengue and" exact="chikungunya" post="from the Americas to Asia. Dengue Bulletin 2010; 34."/>
  <result pre="for South-East Asia, 2010. 27BlochD. The cost and burden of" exact="chikungunya" post="in the Americas. New Haven EliScholar, USA: Yale University;"/>
  <result pre="of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against" exact="chikungunya" post="virus. Vaccine. 2012;30(43):6142â€&quot;9. 10.1016/j.vaccine.2012.07.072 .22884660 32LevittNH, RamsburgHH, HastySE, RepikPM,"/>
  <result pre="HastySE, RepikPM, ColeFE, LuptonHW. Development of an attenuated strain of" exact="chikungunya" post="virus for use in vaccine production. Vaccine. 1986;4(3):157â€&quot;62. 3020820"/>
  <result pre="PerryJG, MangiaficoJA. Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218. Am J Trop Med Hyg. 2000;62(6):681â€&quot;5."/>
  <result pre="2014/01/10. 10.1093/infdis/jiu01424403555 41PlanteK, WangE, PartidosCD, WegerJ, GorchakovR, TsetsarkinK, et al.Novel" exact="chikungunya" post="vaccine candidate with an IRES-based attenuation and host range"/>
  <result pre="ThomasSJ, et al.Immunogenicity, safety, and tolerability of a recombinant measles-virus-based" exact="chikungunya" post="vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet"/>
  <result pre="Dis. 2015;9(10):e000411910.1371/journal.pntd.000411926492074 48ErasmusJH, AugusteAJ, KaelberJT, LuoH, RossiSL, FentonK, et al.A" exact="chikungunya" post="fever vaccine utilizing an insect-specific virus platform. Nat Med."/>
  <result pre="DowdKA, MendozaFH, SaundersJG, SitarS, PlummerSH, et al.Safety and tolerability of" exact="chikungunya" post="virus-like particle vaccine in healthy adults: a phase 1"/>
  <result pre="CoudercT, NgLF, HallengardD, PowersA, LecuitM, et al.Therapeutics and vaccines against" exact="chikungunya" post="virus. Vector Borne Zoonotic Dis. 2015;15(4):250â€&quot;7. 10.1089/vbz.2014.1681 .25897811 53SinghP,"/>
  <result pre="et al.Current research and clinical trials for a vaccine against" exact="chikungunya" post="virus. Vaccine Development and Therapy. 2013;3:35â€&quot;46. 54WhiteheadSS, SubbaraoK. Which"/>
  <result pre="ShedlockDJ, BaoH, KawalekarOU, FagoneP, RamanathanAA, et al.A DNA vaccine against" exact="chikungunya" post="virus is protective in mice and induces neutralizing antibodies"/>
  <result pre=".29194012 63BrandlerS, RuffieC, CombredetC, BraultJB, NajburgV, PrevostMC, et al.A recombinant" exact="measles" post="vaccine expressing chikungunya virus-like particles is strongly immunogenic and"/>
  <result pre="CombredetC, BraultJB, NajburgV, PrevostMC, et al.A recombinant measles vaccine expressing" exact="chikungunya" post="virus-like particles is strongly immunogenic and protects mice from"/>
  <result pre="is strongly immunogenic and protects mice from lethal challenge with" exact="chikungunya" post="virus. Vaccine. 2013;31(36):3718â€&quot;25. Epub 2013/06/08. 10.1016/j.vaccine.2013.05.086 .23742993 64HallengardD, LumFM,"/>
 </snippets>
</snippetsTree>
